Columbia Financial exec granted stock deferral units
Columbia Financial, Inc. executive John Klimowich, SEVP & Chief Risk Officer, reported an indirect acquisition of 589.1476 shares of Common Stock-equivalent phantom stock at $17.4800 per unit on March 13, 2026.
Rhea-AI Filing Summary
Columbia Financial, Inc. executive John Klimowich, SEVP & Chief Risk Officer, reported an indirect acquisition of 589.1476 shares of Common Stock-equivalent phantom stock at $17.4800 per unit on March 13, 2026. The units were credited under a Columbia Bank stock-based deferral plan and are held in a rabbi trust on a non-discretionary basis by the plan trustee.
After this award, his related deferral-plan balance stands at 8926.8984 stock unit interests, which will be settled in shares upon distribution. Separate from this, he holds direct stock options covering 188235, 12030, 8850, 20310 and 20227 shares of Common Stock at exercise prices between $15.6000 and $18.2800, with expirations from 2029 through 2036.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 589.1476 shares
Grant/Award
15 txns
Insider
Klimowich John
Role
SEVP & Chief Risk Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 589.1476 | $17.48 | $10K |
| holding | Stock Options (right to buy) | -- | -- | -- |
| holding | Stock Options (right to buy) | -- | -- | -- |
| holding | Stock Options (right to buy) | -- | -- | -- |
| holding | Stock Options (right to buy) | -- | -- | -- |
| holding | Stock Options (right to buy) | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 8,926.8984 shares (Indirect, By Stock-Based Deferral Plan);
Stock Options (right to buy) — 249,652 contracts (Direct);
Common Stock — 61,464 shares (Direct);
Common Stock — 17,130 shares (Indirect, By 401(k));
Common Stock — 7,620 shares (Indirect, By ESOP);
Common Stock — 7,051 shares (Indirect, By SERP);
Common Stock — 4,214 shares (Indirect, By SIM);
Common Stock — 13,781 shares (Indirect, By Stock Award II);
Common Stock — 10,971 shares (Indirect, By Stock Award III);
Common Stock — 11,723 shares (Indirect, By Stock Award IV);
Common Stock — 11,906 shares (Indirect, By Stock Award V)
Footnotes (10)
- F1. Represents phantom stock purchased, on a non-discretionary basis, by the trustee of the Bank's rabbi trust maintained in connection with the Columbia Bank Stock Based Deferral Plan, a non-qualified stock-based deferral plan. Stock unit interests under the Columbia Bank Stock Based Deferral Plan will be settled in shares of stock upon distribution to the reporting person.
- F2. Stock Awards granted pursuant to the Columbia Financial, Inc. 2019 Equity Incentive plan, 25% of which vest in three approximately equal annual installments commencing on May 1, 2024; and the remaining 75% of which vest upon achievement of certain specified performance-based vesting criteria, which if achieved, such Awards would vest three years after the date of the Award.
- F3. Stock Awards granted pursuant to the Columbia Financial, Inc. 2019 Equity Incentive plan, 25% of which vest in three approximately equal annual installments commencing on March 6, 2025; and the remaining 75% of which vest upon achievement of certain specified performance-based vesting criteria, which if achieved, such Awards would vest three years after the date of the Award.
- F4. Stock Awards granted pursuant to the Columbia Financial, Inc. 2019 Equity Incentive plan, which vest upon achievement of certain specified performance-based vesting criteria, which if achieved, such Awards would vest three years after the date of the Award on March 3, 2028.
- F5. Stock Awards granted pursuant to the Columbia Financial, Inc. 2019 Equity Incentive plan, which vest upon achievement of certain specified performance-based vesting criteria, which if achieved, such Awards would vest three years after the date of the Award on March 2, 2029.
- F6. Stock Options granted pursuant to the Columbia Financial, Inc. 2019 Equity Incentive Plan are fully vested and exercisable.
- F7. Stock Options granted pursuant to the Columbia Financial, Inc. 2019 Equity Incentive Plan vest in three approximately equal annual installments commencing on May 1, 2024.
- F8. Stock Options granted pursuant to the Columbia Financial, Inc. 2019 Equity Incentive Plan vest in three approximately equal annual installments commencing on March 6, 2025.
- F9. Stock Options granted pursuant to the Columbia Financial, Inc. 2019 Equity Incentive Plan vest in three approximately equal annual installments commencing on March 3, 2026.
- F10. Stock Options granted pursuant to the Columbia Financial, Inc. 2019 Equity Incentive Plan vest in three approximately equal annual installments commencing on March 2, 2027.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Columbia Financial (CLBK) disclose in John Klimowich’s latest Form 4?
Columbia Financial reported that executive John Klimowich indirectly acquired 589.1476 phantom stock units at $17.4800 on March 13, 2026. These units were credited under a stock-based deferral plan and will eventually be settled in shares upon distribution to him.
Is John Klimowich’s Form 4 for CLBK a stock purchase or a compensation award?
The filing reflects a compensation-related award, not an open-market stock purchase. Klimowich received 589.1476 phantom stock units credited under a Columbia Bank stock-based deferral plan, with the trustee acquiring the units on a non-discretionary basis for his account.
How many Columbia Financial (CLBK) deferral-plan units does John Klimowich hold after this transaction?
Following the reported award, John Klimowich’s balance under the Columbia Bank stock-based deferral plan totals 8926.8984 stock unit interests. According to the disclosure, these units are designed to be settled in shares of Columbia Financial common stock upon distribution to him.
What stock option positions for CLBK does John Klimowich report in this Form 4?
Klimowich reports several outstanding stock option grants on Columbia Financial common stock, including positions over 188235, 12030, 8850, 20310 and 20227 underlying shares. Exercise prices range from $15.6000 to $18.2800, with expirations between 2029 and 2036.
Are the phantom stock units in the CLBK filing held directly by John Klimowich?
No. The phantom stock units are held indirectly through a rabbi trust for a stock-based deferral plan. The trustee purchases the units on a non-discretionary basis, and they are scheduled to be settled in shares of Columbia Financial common stock upon future distribution.
AI-generated analysis. How Rhea-AI works. Not financial advice.
